In vivo experimental, data indicated that TIM‐4 overexpression elevated the Treg proportion, while decreased the proportion of CD8+Tc cells, indicating that TIM‐4 affected CD8+Tc cells through Treg, and CD8+ Tc cells' killing effect on tumor cells ultimately affected tumor growth. This evidence concerns the gene CD8A and neoplasm.